Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2010
06/15/2010US7737156 6-(Cyclohexylmethyl)-1-(1-ethylpropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, administered to humans or animals, to improve perception, concentration, cognition, learning and/or memory, as a consequence of dementia, stroke, brain trauma, Alzheimer's disease, Parkinson's disease or depression
06/15/2010US7737155 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases
06/15/2010US7737154 CRF receptor antagonists and methods relating thereto
06/15/2010US7737148 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors
06/15/2010US7737143 such as 6-(1H-Benzimidazol-1-yl)-N-benzylpyrazin-2-amine, used as antidiabetic, anticarcinogenic and antiarthritic agents or for treating autoimmune diseases
06/15/2010US7737142 (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
06/15/2010US7737118 Alternating intrathecal administration to the mammal of a pharmaceutically effective dose of opioid receptor agonist for first period of time, and dose of at least one opioid receptor-like receptor 1 agonist for a second period of time
06/15/2010US7736856 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent
06/15/2010US7736665 Implantable polymeric device for sustained release of buprenorphine
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010CA2538915C [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
06/15/2010CA2493391C Novel thiophene glycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
06/15/2010CA2491394C 1h-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-cb1 receptor ligands
06/15/2010CA2463668C Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof
06/15/2010CA2442256C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
06/15/2010CA2440648C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
06/15/2010CA2419875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
06/15/2010CA2393650C Novel 1,8-naphthyridin-2(1h)-one derivatives
06/15/2010CA2383340C Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
06/15/2010CA2379103C Novel spiro compounds
06/15/2010CA2341700C Compositions and methods for treatment of mitochondrial diseases
06/15/2010CA2335505C Novel triterpenoids and their use for the treatment and prevention of cancer, inflammatory disorders, and neurodegenerative disease
06/15/2010CA2328922C Terminally-branched polymeric linkers and polymeric conjugates containing the same
06/15/2010CA2328440C Heterocyclically substituted amides used as calpain inhibitors
06/15/2010CA2294472C Torsin, torsin genes, and methods of use
06/10/2010WO2010065889A2 Cyclobutanemethanamine inhibitors of monomine reuptake
06/10/2010WO2010065803A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
06/10/2010WO2010065801A1 Amine substituted piperazine melanocortin receptor-specific compounds
06/10/2010WO2010065798A1 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
06/10/2010WO2010065743A2 Bicyclic compounds and methods of making and using same
06/10/2010WO2010065709A2 Hydroxamic acid derivatives, preparation and therapeutic uses thereof
06/10/2010WO2010065701A1 Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative
06/10/2010WO2010065449A1 (r) -3- (e) -2- (pyrr0lidin-3-yl) vinyl) -5- (tetrahydr0pyran-4-yl0xy) pyridine, its salts, its synthesis and its use as ligand for nicotinic acetylcholinergic receptors
06/10/2010WO2010065443A1 Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine
06/10/2010WO2010065117A1 Inhibition of hdac2 to promote memory
06/10/2010WO2010064737A1 Heterocyclic compound and use of the same
06/10/2010WO2010064707A1 2h-chromene compound and derivative thereof
06/10/2010WO2010064705A1 Novel 7-substituted dihydropyranopyrimidine derivative having h4 receptor antagonistic activity
06/10/2010WO2010064701A1 Pharmaceutical agent comprising quinolone compound
06/10/2010WO2010064665A1 Therapeutic agents
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010064416A1 Instrument for alleviating addictive drug craving, method for using same and method for treating addictive drug dependence
06/10/2010WO2010064248A2 Methods of diagnosing and treating motor neuron diseases
06/10/2010WO2010064246A2 A mother-baby kit for treating emotional conditions before, during and after giving birth
06/10/2010WO2010064047A1 Use of sabcomeline for the treatment of add or adhd
06/10/2010WO2010063910A1 Use of geranyl-geranyl transferase in treating spinal cord lesions
06/10/2010WO2010063721A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
06/10/2010WO2010063666A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
06/10/2010WO2010063663A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010063662A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
06/10/2010WO2010063610A1 Pyridazinone derivatives
06/10/2010WO2010063487A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
06/10/2010WO2010063486A1 Use of eltoprazine for the treatment of l-dopa-induced dyskinesia
06/10/2010WO2010063292A1 Nalmefene hydrochloride dihydrate
06/10/2010WO2010029131A9 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
06/10/2010WO2010028134A3 Treatment of neurological disorders using huperzine
06/10/2010WO2010028130A3 Antidepressant compounds
06/10/2010WO2010027875A3 Compounds that modulate intracellular calcium
06/10/2010WO2010025251A3 Materials and methods for modulating appetite, weight gain and adhd using varenicline
06/10/2010WO2010011331A3 Compositions and methods related to sirt1 function
06/10/2010WO2010002956A3 Heterocyclic derivatives as modulators of ion channels
06/10/2010WO2009149486A3 Compounds for treating beta-amyloidoses
06/10/2010WO2009149485A3 Compounds for treating amyloidoses
06/10/2010WO2009147170A3 Drug combinations comprising a dgat inhibitor and a ppar-agonist
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100145040 Benzazepine Derivatives For The Treatment of Neurological Disorders
06/10/2010US20100144891 Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
06/10/2010US20100144887 Crystalline solid rasagiline base
06/10/2010US20100144886 Method for treating pulmonary arterial hypertension
06/10/2010US20100144876 Modulator
06/10/2010US20100144875 Compositions and Methods for Preserving Brain Function
06/10/2010US20100144869 Conjugates Comprising a gaba-or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders
06/10/2010US20100144868 Novel Neuroprotective Compounds and Uses Thereof
06/10/2010US20100144862 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
06/10/2010US20100144860 Transglutaminase Inhibitor Comprising EGCG And A Method For Producing Thereof
06/10/2010US20100144858 Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
06/10/2010US20100144857 Prenylflavanone compounds and uses thereof
06/10/2010US20100144856 Prenylfavanone compounds and uses thereof
06/10/2010US20100144829 Novel Receptor Antagonists and Their Methods of Use
06/10/2010US20100144821 Compounds and methods for treating protein folding disorders
06/10/2010US20100144816 Functionally selective alpha2c adrenoreceptor agonists
06/10/2010US20100144812 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production Containing an Azole
06/10/2010US20100144809 Novel benzamidine derivatives useful as potassium channel modulators
06/10/2010US20100144799 Optical enantiomers of phenyramidol and process for chiral synthesis
06/10/2010US20100144795 Treatment of attention-deficit/hyperactivity disorder
06/10/2010US20100144793 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
06/10/2010US20100144790 Use of Thalidomide for Alzheimers Disease Treatment and Prevention
06/10/2010US20100144789 1-Isopropyl-2-Oxo-1,2-dihydropyridine-3-carboxamide Derivatives having 5-HT4 Receptor Agonistic Activity
06/10/2010US20100144788 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
06/10/2010US20100144776 Use of snps for the diagnosis of a pain protective haplotype in the gtp cyclohydrolase 1 gene (gch1)
06/10/2010US20100144773 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid
06/10/2010US20100144768 Kinase inhibitor compounds
06/10/2010US20100144767 Use of sodium channel blockers for the treatment of visceral pain or pain caused by cancer treatment
06/10/2010US20100144764 Pyrimidinedione derivatives and methods of use thereof
06/10/2010US20100144760 Novel compounds
06/10/2010US20100144757 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
06/10/2010US20100144756 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/10/2010US20100144755 Novel Compounds
06/10/2010US20100144754 Methods and Compositions for Treating or Preventing Narcotic Withdrawal Symptoms
06/10/2010US20100144750 Use of N-Phenyl-2-Pyrimidineamine Derivatives Against Mast Cell-Based Diseases Like Allergic Disorders
1 ... 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 ... 1833